Related Experiment Video
Updated: Jul 31, 2025

Detection and Visualization of DNA Damage-induced Protein Complexes in Suspension Cell Cultures Using the Proximity Ligation Assay
Published on: June 9, 2017
PHLDA1 is a P53 target gene involved in P53-mediated cell apoptosis
Xuhong Song1,2, Lulu Zhou2, Wenrui Yang2
1Center for Cancer Research, Shantou University Medical College, Shantou, Guangdong, China.
Abstract:
Pleckstrin homeolike domain, family A, member 1 (PHLDA1) is a multifunctional protein that plays diverse roles in A variety of biological processes, including cell death, and hence its altered expression has been found in different types of cancer. Although studies have shown a regulatory relationship between p53 and PHLDA1, the molecular mechanism is still unclear. Especially, the role of PHLDA1 in the process of apoptosis is still controversial. In this study, we found that the expression of PHLDA1 in human cervical cancer cell lines was correlated with the up-expression of p53 after treatment with apoptosis-inducing factors. Subsequently, the binding site and the binding effect of p53 on the promoter region of PHLDA1 were verified by our bioinformatics data analysis and luciferase reporter assay. Indeed, we used CRISPR-Cas9 to knockout the p53 gene in HeLa cells and further confirmed that p53 can bind to the promoter region of PHLDA1 gene, and then directly regulate the expression of PHLDA1 by recruiting P300 and CBP to change the acetylation and methylation levels in the promoter region. Finally, a series of gain-of-function experiments further confirmed that p53 re-expression in HeLap53-/- cell can up-regulate the reduction of PHLDA1 caused by p53 knockout, and affect cell apoptosis and proliferation. Our study is the first to explore the regulatory mechanism of p53 on PHLDA1 by using the p53 gene knockout cell model, which further proves that PHLDA1 is a target-gene in p53-mediated apoptosis, and reveals the important role of PHLDA1 in cell fate determination.
Insights
The tumor suppressor p53 directly regulates Pleckstrin homeolike domain, family A, member 1 (PHLDA1) expression by binding its promoter. This reveals PHLDA1 as a target gene in p53-mediated apoptosis and cell fate determination.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Background:
- Pleckstrin homeolike domain, family A, member 1 (PHLDA1) is implicated in cell death and cancer, with a known but mechanistically unclear link to the p53 tumor suppressor.
- The precise role of PHLDA1 in apoptosis remains controversial, necessitating further investigation into its regulatory pathways.
Purpose of the Study:
- To elucidate the molecular mechanism by which p53 regulates PHLDA1 expression.
- To determine if PHLDA1 is a direct target gene of p53 in the context of apoptosis and cell fate.
Main Methods:
- Bioinformatics analysis and luciferase reporter assays to identify p53 binding sites on the PHLDA1 promoter.
- CRISPR-Cas9 gene editing to create p53 knockout HeLa cells (HeLap53-/-).
- Gain-of-function experiments involving p53 re-expression in knockout cells to assess PHLDA1 regulation, apoptosis, and proliferation.
Main Results:
- p53 was confirmed to bind the PHLDA1 promoter, directly regulating its expression.
- p53 recruits histone acetyltransferases (P300 and CBP) to alter promoter acetylation and methylation, thereby controlling PHLDA1 transcription.
- p53 knockout reduced PHLDA1 levels, impacting cell apoptosis and proliferation, which was reversed upon p53 re-expression.
Conclusions:
- PHLDA1 is a direct transcriptional target of p53, playing a crucial role in p53-mediated apoptosis.
- The p53-PHLDA1 regulatory axis is vital for determining cell fate, offering potential therapeutic targets in cancer treatment.
Related Concept Videos
Abnormal Proliferation
The Intrinsic Apoptotic Pathway
DNA Damage can Stall the Cell Cycle
Negative Regulator Molecules
The Extrinsic Apoptotic Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

